Clinical Trial

Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy

Study acronym: COLP PAO
Recruiting
View on ClinicalTrials.gov →
Summary
In this randomized controlled trial, 64 participants undergoing PAO at UCSF will be enrolled and randomized to receive either COLP plus treatment as usual (TAU) or TAU alone. Patients in the COLP arm will receive placebo pills alongside prescribed opioids and at scheduled intervals, beginning on postoperative day one. Weekly follow-up will be conducted for six weeks postoperatively via remote surveys and video visits.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-22; most recent amendment 2026-04-28.
Trial Details
NCT Number NCT07373210
Lead Sponsor University of California, San Francisco
Conditions Periacetabular Osteotomy, Opiates
Enrollment 64 participants
Start Date 2026-12
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-29